Abstract. Chrysanthemum indicum Linné (Asteraceae) is a common Chinese herbal medicine that has been traditionally used for the treatment of inflammation, hypertension and neoplastic diseases in China. However, the mechanism that account for the inhibitory activity of Chrysanthemum indicum Linné against cancer cells is poorly understood. We investigated the effect of Chrysanthemum indicum Linné extracts (CILE) on isoproterenol (ISO) induced growth of human hepatocellar carcinoma (HCC) cells in correlation with the intracellular activity of MAPK/ERK1/2. We found that CILE was effective in attenuating the mitogenic effect of ISO on both HepG2 and MHCC97H cells. The inhibitory effect of CILE was mediated by inhibiting the ISO-induced activation of MAPK/ ERK1/2 via ß2-AR in tumor cells. Our findings will be helpful in understanding the anticancer mechanism of CILE.
Introduction
Chrysanthemum indicum Linné (Asteraceae) is a common Chinese herbal medicine that has been traditionally used for the treatment of inflammation, hypertension and neoplastic diseases in China (1) (2) (3) . Modern pharmacological research demonstrates that chrysanthemum indicum Linné extracts (CILE) possess several effective compositions such as flavonoids, terpenoids and phenolic compounds that have antibacterial, antivirus, anti-inflammatory, anti-sympathetic, antioxidant, and anti-neoplastic functions (4) (5) (6) (7) . These data indicate that there are great chances of finding new anticancer agents from Chinese pharmacy. However, the traditional use of Chrysanthemum indicum Linné for treatment of cancers in Chinese medicine is rather perplexing and the molecular mechanisms that account for the inhibitory activity of Chrysanthemum indicum Linné against cancer cells are poorly understood.
Recent studies emphasize the influences of psychological stress on cancer progression. The effects of psychological stress on cancer cells are mediated by the key stress hormones and their corresponding receptors (8, 9) . A number of studies demonstrate that catecholamine activates the mitogenactivated protein kinase (MAPK)/extracellular signal-regulated kinase1/2 (ERK1/2) signaling pathway via ß2-adrenergic receptor to promote the growth of cancer cells (10) (11) (12) . The ERK pathway is a component of the MAPK cascade and consists of two isoenzymes, namely ERK1/2, also called p44ERK1 and p42ERK2. Activated ERK1/2 translocate into nuclei and activate transcription factors to increase transcription of genes relevant for cell growth and invasion (13, 14) . Recent studies demonstrate that CILE also modulate the activity of MAPK/ERK1/2 in immune and cardiovascular cells that contribute to the anti-inflammatory, anti-sympathetic and antioxidant effects (15) (16) (17) (18) . These data indicate that CILE possess a certain antagonistic function against stress hormones.
In the present study, we investigated the antagonistic effect of CILE on the ß-AR agonist isoproterenol (ISO) induced growth of human hepatocellar carcinoma (HCC) cells, in correlation with the adrenergic receptors and the activity of ERK1/2 in tumor cells. Subsequently, 20 μl of MTT (5 g/l) was added to each well and incubated for an additional 4 h. Plates were centrifuged for 5 min at 1000 rpm, and the medium was carefully discarded. The formed formazan crystals were dissolved in 100 μl of DMSO, and absorbance was read at 570 nm using a spectrophotometer.
Materials and methods

Chemicals and antibodies. (±)-Isoproterenol hydrochloride and (
Western blot analysis. HepG2 and MHCC97H cells were washed twice in phosphate-buffered saline (PBS), lysed in ice-cold radioimmune precipitation (RIPA) buffer, and then centrifuged for 10 min at 4˚C. Supernatant was collected and protein concentrations were determined and adjusted to 2 mg/ml using the Bio-Rad kit (Bio-Rad Laboratories, Hercules, CA, USA). Cell lysates were mixed with 3X Laemmli buffer and heated for 5 min at 95˚C. They were then resolved by SDS-PAGE (10% polyacrylamide gels), transferred to polyvinylidene difluoride membrane (Immobilon™; Millipore Corp.) by electroblotting. The membrane was blotted with 10% nonfat milk, washed in TBS Tween and incubated with primary rabbit polyclonal antibodies overnight at 4˚C. After washing with TBS Tween, they were incubated with secondary antibody solution (horseradish peroxidase conjugated IgG) for 60 min at room temperature. Membranes were washed again with TBS Tween before detection using the enhanced chemiluminescence detection system (Amersham Pharmacia Biotech, Piscataway, NJ, USA). The following primary antibodies were used at dilutions: anti-ERK1/2, 1:800; anti-phospho-ERK1/2, 1:800; anti-ß-actin, 1:400; secondary antibody was used at dilutions of 1:10000.
Flow cytometric analysis. HepG2 and MHCC97H cells were plated in six-well plates at 3x10 5 per well. Cells were serumstarved overnight before compound treatment. After incubated with ISO in absence or presence of ICI 118551, U0126 and CILE for the indicated times, cells were harvested by trypsinization and washed with PBS. Cells were fixed in ice-cold 80% ethanol, washed, and resuspended in 1 ml PBS; treated with 10 μl RNase A (21 mg/ml); and stained with 5 μl propidium iodide at 1 mg/ml for 30 min at room temperature in the dark. The stained cells were analyzed by flow cytometry (BD LSRII System, BD Biosciences, San Jose, CA, USA). Gating was set to exclude cell debris, cell doublets, and cell clumps. To evaluate the cell cycle distribution of apoptotic cells in response to serum-deprivation, the treated cells were washed in PBS, resuspended in 100 ml binding buffer containing FITC-conjugated Annexin V (Becton Dickinson, San Jose, CA, USA) and propidium iodide (PI) to discriminate apoptotic cells from live cells and necrotic cells. Annexin V(+)/PI(-) and Annexin V(+)/PI(+) represent the cells in early apoptosis and late apoptosis/necrosis, respectively.
Statistical analysis.
Immunoblot signals were first quantitated using densitometry and ImageJ software (version 1.34s; by Wayne Rasband, NIH, Bethesda, MD, USA). Results were expressed as the mean ± SEM of three separate experiments and analyzed by the computer program SPSS 10.0 for Windows (SPSS Inc., Chicago, IL), using one-way analysis of variance (ANOVA) followed by the Turkey's t-test. P<0.05 were considered statistically significant.
Results
Chrysanthemum indicum Linné extract (CILE) inhibited the growth-promoting effect of the ß-AR agonist isoproterenol (ISO) on HepG2 and MHCC97H.
Our previous study demonstrated that ·1-adrenergic receptor (·1-AR) was downregulated while ß2-adrenergic receptor (ß2-AR) was upregulated in both HepG2 and MHCC97H cells (Fig. 1A-C) , we selected the specific ß-AR agonist isoproterenol (ISO) as a stimulant. The growth-promoting effect of ISO and the inhibitory effect of CILE on HepG2 and MHCC97H cells were determined using the MTT assay. ISO dose-dependently stimulated the proliferation of HepG2 and MHCC97H cells ( Fig. 2A and B) . The growth enhancement was initiated at a dose of 100 nM of ISO and peaked at a dose of 10000 nM of ISO with the maximum increases in proliferation (HepG2 was 215±2% and MHCC97H was 207±4% versus control, respectively, p<0.05). Strikingly, the ISO-induced growth of HepG2 and MHCC97H cells was significantly inhibited in the presence of CILE (from 0.4 mg/ml to 1.6 mg/ml), and the maximum inhibitory effect of CILE was present at the dose of 1.6 mg/ml. The maximum decrease in proliferation of HepG2 was 89±2%, and the maximum decrease in proliferation of MHCC97H was 86±3% relatively to the subgroup of ISO in absence of CILE, p<0.05 (Fig. 2C) .
Isoproterenol activated MAPK/ERK1/2 in HepG2 and MHCC97H cells.
We then were curious about whether ISO could activate MAPK/ERK1/2 signaling pathway in HepG2 and MHCC97H cells. ISO (10 μM) was added to the medium and the levels of phosphorylated-ERK1/2 (pERK1/2) were determined by Western blotting. The addition of ISO resulted in an immediate activation of ERK1/2 in both HepG2 and MHCC97H cells (Fig. 3A and B) . As early as 15 min after the addition of ISO, pERK1/2 was increased by an average of 3.49/3.02-fold in HepG2 (Fig. 3A ) and 3.15/2.33-fold in MHCC97H (Fig. 3B) . We used the selective antagonist of ß2-AR, ICI 118551 to confirm the ß2-AR signaling. The specificity of ISO-induced phosphorylation of ERK1/2 was demonstrated using the MEK-specific inhibitor, U0126. Both ICI 118551 (5 μM) and U0126 (10 μM) efficiently blocked the increases of pERK1/2 ( Fig. 3C and D) .
Mitogenic effect of isoproterenol on HepG2 and MHCC97H cells was significantly attenuated by Chrysanthemum indicum Linné extract.
We added CILE to the medium to see whether the ISO-induced activation of MAPK/ERK1/2 could be blocked. Cells were incubated with 1.2 mg/ml of CILE in absence or presence of 10 μM of ISO. CILE slightly inhibited the activities of ERK1/2 in absence of ISO. However, the inhibitory effect of CILE on ERK1/2 was more significant in the presence of ISO (Fig. 4A and B) . We further examined the inhibitory effect of CILE on the proliferation of HepG2 control, respectively, p<0.05) were significantly attenuated in presence of ICI, U0126 or CILE (Fig. 4C) . (Fig. 5A1, A2 , and A11; (Fig. 5A6, A7 and A12; Fig. 5B6, B7 and B12 ). These effects of ISO were significantly blocked in presence of ICI 118551, CILE and U0126 (Fig. 5A3, A4 , A5 and A11; 5B3, B4, B5 and B11; Fig. 5A8 , A9, A10, A12; 5B8, B9, B10 and B12). Meanwhile, the percentage of cells in the G0/G1 phase of both HepG2 and MHCC97H was greatly increased in presence of ICI 118551, U0126 and CILE.
Effect of Chrysanthemum indicum Linné extract on
Discussion
Previous studies demonstrated that CILE was cytotoxic to lung, colon, prostate, kidney cancer and melanoma cells (1-6). 
A
The inhibitory activity against cancer cells is suggested to be due to the anti-oxidant, anti-inflammatory, and immunomodulatory functions of CILE. In the present study, we demonstrated that CILE inhibited tumor cell growth by attenuating the mitogenic effect of sympathetic stimulation on human HCC cells. Firstly, we provided evidence that the specific ß-AR agonist isoproterenol (ISO) was a mitogen for human HCC cells and the effect of ISO was efficiently inhibited by CILE. Exposure of HepG2 and MHCC97H cells to ISO resulted in an increased cell proliferation ( Fig. 2A and B) , enhanced cell survival ( Fig. 5A2 and A11 ; Fig. 5B2 and B11 ) and accelerated cell cycle progression ( Fig. 5A7 and A12 ; Fig. 5B7 and B12 ). The increases in growth were proven to be dose-dependent, which was initiated by 100 nM of ISO and peaked by 10000 nM of ISO ( Fig. 2A and B) . However, the deleterious effect of ISO on the growth of both HepG2 and MHCC97H cells was effectively attenuated by the treatment of CILE ( Fig. 2C;  Fig. 5A5, A11, A10 and A12; Fig. 5B5 , B11, B10 and B12).
Secondly, we provided a primary insight into the possible mechanism that account for the stimulatory effect of ISO and antagonistic effect of CILE on the growth of HepG2 and MHCC97H cells. Clinical studies demonstrated that human HCC exhibited high expression of MAPK/ERK1/2 and the enhanced activity of MAPK/ERK1/2 was associated with rapid tumor progression and poor prognosis (13, 14) . We focus our study on the stimulatory effect of ISO and the inhibitory effect of CILE on MAPK/ERK1/2 in HepG2 and MHCC97H cells. We found that ISO transiently activated the ERK1/2 in both tumor cell lines (Fig. 3A and B) . Moreover, the stimulatory effect of ISO on ERK1/2 was significantly attenuated by the selective ß2-AR antagonist ICI 118551, the MEK inhibitor U0126 and CILE ( Fig. 3C and D; Fig. 4A and B), resulting in an inhibition of tumor cell growth ( Fig. 4C ; Fig. 5A3 -A5 and A8-A12; Fig. 5B3-B5 and B8-B12) . Thus, we demonstrated that CILE was competent in attenuating the stimulatory effect of ISO on ERK1/2 in tumor cells.
In conclusion, our data show that CILE was effective in attenuating the mitogenic effect of ISO on HepG2 and 
B
MHCC97H cells. The inhibitory effect of CILE was mediated by inhibiting the ISO-induced activation of MAPK/ERK1/2 via ß2-AR in tumor cells. Our findings will be helpful for understanding the anticancer mechanism of CILE.
